In an animal model of mice with transplanted genetically engineered BRCA1-deficient (BRCA1−/−) breast cancer, the animals treated with NVB had significantly smaller tumors and lived almost three times longer than those treated with vehicle. The gene discussed is BRCA1; the disease is breast carcinoma.